Skip to main content
Log in

Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Bonn Risk Index (BRI) is being used for the assessment of urinary calcium oxalate (CaOx) crystallization. There are no published data regarding BRI during growth. The objective of this study was to establish age- and sex-dependent BRI values in healthy children and adolescents. A total of 1,050 Caucasian subjects aged 3–18 years (525 males, 525 females) without a history of kidney stone disease were enrolled in the cross-sectional study. The study group was divided into 15 ranges according to age, each comprising 70 subjects. Urinary ionized calcium [Ca2+] was measured using a selective electrode while the onset of spontaneous crystallization was determined using a photometer and titrating with 40 mmol/L ammonium oxalate (Ox2−). The calculation of BRI value was based on the ratio of [Ca2+] to the required amount of ammonium oxalate added to 200 ml of urine to induce crystallization. The median BRI was 0.26 1/L and the values of the 5th and 95th percentiles were 0.06 1/L and 1.93 1/L, respectively. BRI correlated positively with body-area-related BRI (1/L × 1.73 m2) (R = 0.18; P < 0.05), whereas a negative correlation was found between BRI and body weight (1/L × kg) (R = −0.85; P < 0.05). Neither sex nor age differences were detected in BRI across studied children and adolescents. The values of Bonn Risk Index were constant during growth and there was a limited influence of age and sex on BRI in children over 3 years of age. The BRI may be valuable in the evaluation of pediatric patients at risk for kidney stones, particularly if the BRI from stone formers is demonstrated to be higher than in normal children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AP:

activity product

BMI:

Body Mass Index

BRI:

Bonn Risk Index

[Ca2+]:

ionized calcium concentration

CaOx:

calcium oxalate

(Ox2−):

amount of ammonium oxalate added to 200 ml of urine to induce crystallization

References

  1. Kraus SJ, Lebowitz RL, Royal SA (1999) Renal calculi in children: imaging features that lead to diagnoses: a pictorial essay. Pediatr Radiol 29:624–630

    Article  CAS  Google Scholar 

  2. Cameron MA, Sakhaee K, Moe OW (2005) Nephrolithiasis in children. Pediatr Nephrol 20:1587–1592

    Article  Google Scholar 

  3. Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31:927–949

    Article  CAS  Google Scholar 

  4. Sayer JA, Carr G, Simmons NL (2004) Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci 106:549–561

    Article  CAS  Google Scholar 

  5. Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A (2003) Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 8:437–443

    Article  Google Scholar 

  6. Kavanagh JP, Laube N (2006) Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls? J Urol 175:766–770

    Article  Google Scholar 

  7. Tiselius HG (1997) Risk formulas in calcium oxalate urolithiasis. World J Urol 15:176–185

    Article  CAS  Google Scholar 

  8. Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 134:1242–1244

    Article  CAS  Google Scholar 

  9. Laube N, Schneider A, Hesse A (2000) A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine. Urol Res 28:274–280

    Article  CAS  Google Scholar 

  10. Lewandowski S, Rodgers AL, Laube N, von Unruh G, Zimmermann D, Hesse A (2005) Oxalate and its handling in a low stone risk vs a stone-prone population group. World J Urol 6:1–4

    Google Scholar 

  11. Kunachowicz H, Nadolna I, Przygoda B, Iwanow K (1998) Food composition tables. National Food and Nutrition Institute, Warsaw

  12. Laube N, Hergarten S, Hesse A (2002) Comparison of a laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate. Clin Chem Lab Med 40:595–599

    Article  CAS  Google Scholar 

  13. Palczewska I, Szilágyi-Pągowska I (2002) Ocena rozwoju somatycznego dzieci i młodzieży. Med Prakt Ped 3200:140–148

    Google Scholar 

  14. Chandhoke PS (2002) When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol 168:937–940

    Article  Google Scholar 

  15. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823

    Article  Google Scholar 

  16. Kok DJ (2002) Clinical implications of physicochemistry of stone formation. Endocrinol Metab Clin North Am 31:855–867

    Article  CAS  Google Scholar 

  17. Kavanagh JP (2006) In vitro calcium oxalate crystallisation methods. Urol Res 14:1–7

    Google Scholar 

  18. Hoppe B, Jahnen A, Bach D, Hesse A (1997) Urinary calcium oxalate saturation in healthy infants and children. J Urol 158:557–559

    Article  CAS  Google Scholar 

  19. Lande MB, Varade W, Erkan E, Niederbracht Y, Schwartz GJ (2005) Role of urinary supersaturation in the evaluation of children with urolithiasis. Pediatr Nephrol 20:491–494

    Article  Google Scholar 

  20. Laube N, Hergarten S (2005) Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions? J Urol 175:2175–2177

    Article  Google Scholar 

  21. Teller WM, Burke EC, Rosevaer JW, McKenzie BF (1962) Urinary excretion of acid mucopolysaccharides in normal children and patients with gargoylism. J Lab Clin Med 59:95–101

    CAS  PubMed  Google Scholar 

  22. Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL (2002) Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol 167:2372–2376

    Article  CAS  Google Scholar 

  23. Ricchiuti V, Hartke DM, Yang LZ, Goldman HB, Elder JS, Resnick MI, Marengo SR (2002) Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones. BJU Int 99:513–517

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tadeusz Porowski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Porowski, T., Zoch-Zwierz, W., Wasilewska, A. et al. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol 22, 514–520 (2007). https://doi.org/10.1007/s00467-006-0383-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-006-0383-0

Keywords

Navigation